Revenue of leading public synthetic biology companies worldwide 2022
In 2022, Amyris reported around 270 million U.S. dollars in total revenue, while Twist Bioscience reported around 204 million U.S. dollars in total revenue. This statistic illustrates the total revenue of leading public synthetic biology companies worldwide in 2022, in million U.S. dollars.